Drug
IDX 899 clinical trials
Also written GSK2248761.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2010 (6)
| Year | Studies |
|---|---|
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Raltegravir (1) · Simvastatin (1) · Atorvastatin (1) · Rosuvastatin (1) · Darunavir/Ritonavir (1) · Lopinavir-ritonavir drug combination (1) · Dolutegravir (1)
Studies
Open first, then newest update. How each study uses IDX 899 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761CompletedPhase 1ViiV HealthcareNCT01031472Written as GSK2248761 formulation 1
- A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.TerminatedPhase 1ViiV HealthcareNCT01195974Written as GSK2248761
- Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.CompletedPhase 2ViiV HealthcareNCT00945282Written as GSK2248761
- Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV InfectionTerminatedPhase 2ViiV HealthcareNCT01199731Written as GSK2248761 100 mg once daily
- Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)TerminatedPhase 2ViiV HealthcareNCT01231555Written as GSK2248761 100 mg once daily
- A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult SubjectsCompletedPhase 1ViiV HealthcareNCT01101893Written as GSK2248761
- A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435CompletedPhase 1ViiV HealthcareNCT01209117Written as GSK2248761 WBM Capsule
- A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.WithdrawnPhase 1ViiV HealthcareNCT01283100Written as GSK2248761
- A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.CompletedPhase 1GlaxoSmithKlineNCT01138072Written as GSK2248761
- Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe DrugsCompletedPhase 1GlaxoSmithKlineNCT00920088Written as GSK2248761